Engineered delivery systems for vaccine adjuvants

Area of Science:

• Immunology and Materials Science
• Vaccine Development
• Biotechnology

Background:

• Conventional vaccine adjuvants face limitations in targeting precision, release control, and immune response polarization.
• Advanced materials like lipid nanoparticles (LNPs), liposomes, polymers, and metal-organic frameworks (MOFs) offer solutions for improved adjuvant delivery.

Purpose of the Study:

• To systematically categorize contemporary adjuvant delivery strategies using a multidimensional framework.
• To examine how material properties and engineering influence spatial, temporal, and immunological precision of adjuvants.
• To provide a materials-centric roadmap for the design and clinical advancement of precision adjuvants.

Main Methods:

• Systematic categorization of adjuvant delivery strategies across spatial, temporal, and immunological dimensions.
• Analysis of material physicochemical properties, stimuli-responsive architectures, and surface engineering.
• Evaluation of clinical translation progress, including bio-manufacturing, stability, and regulatory aspects.

Main Results:

• A multidimensional framework (spatial, temporal, immunological precision) is presented for evaluating adjuvant delivery systems.
• Material properties and engineering critically regulate adjuvant localization, immune stimulation timing, and response polarization.
• Coordinated optimization of these dimensions is essential for maximizing vaccine efficacy.

Conclusions:

• Next-generation precision adjuvants engineered with advanced materials hold significant promise for enhancing vaccine efficacy.
• Addressing bio-manufacturing scalability, formulation stability, and regulatory challenges is crucial for clinical translation.
• This review provides a practical guide for the rational design and development of advanced adjuvant delivery systems.